Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Benzinga (Video) on MSN16h
Cognition Therapeutics Is Targeting A Critical Form Of DementiaLisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...
News Medical on MSN5h
Early diagnosis of Dementia with Lewy Bodies could be improved by cognitive profilingCognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...
Use of the treatment has soared in popularity in recent years now taken by 2.6million women in England according to the ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Dementia drivers license loophole sparks safety concerns in South Korea Koreas lack of legal measures puts dementia patients ...
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...
Officials are assessing whether hydromethylthionine mesylate (HMTM) shows sufficient promise to be given the green light for ...
2024 saw a new drug enter the dementia landscape, as the U.S. Food and Drug Administration ... more options and greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback